16. The compound: 2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide. 17. The compound having the structure: 18. A crystal comprising a compound having the structure: or a pharmaceutically acceptable salt thereof. 19. The crystal of claim 18...
0 to 2 heteroatoms independently selected from O, S or N; or iv) R10 is hydrogen, and R9 and R11 together with the two carbon atoms to which they are attached, form a three- to six-membered ring with 0 to 2 heteroatoms independently selected from O, S or N; Z is Z1 or Z2; ...
locus_tag = “YALI0D07986g”) Yarrowia lipolytica DGAT1 13 (1578 bp) 14 (526 AA) (“Yl DGAT1”) Yarrowia lipolytica ARE2 (“Yl ARE2”) 15 (1632 bp) 16 (543 AA) Mortierella alpina DGAT1 17 (1578 bp) 18 (525 AA) (“Ma DGAT1”) Mortierella...